
The updated vaccine will be available to eligible groups as part of the 2026/27 NHS vaccination programme

Excessive sweating affects 1-5% of the population and can have a substantial impact on quality of life

The UK is the first country in Europe to authorise the oral medication

A record two million women were prescribed hormone replacement therapy in 2025/26 compared to 0.8 million in 2020/21

The report forecasts a rise in cases in the US, the UK, Canada, Australia and Europe

Against the backdrop of widespread medicine shortages, Durbin PLC’s rebrand to Uniphar and integration into Uniphar | Global Sourcing represents a strategic move to address industry-wide challenges, expanding its sourcing...

SMA is a rare genetic neuromuscular condition affecting around 1,600 people in the UK

Discover the transformative updates to UK clinical trial regulations, effective from April 2026, and learn how they aim to enhance transparency, participant safety, and trial efficiency.

Around 30% of patients saw 80% more scalp hair after 24 weeks of treatment

This is the first approved treatment option in the UK for patients with non-segmental vitiligo

Obesity affects approximately 15 million people in the UK

Symptoms of COPD include breathlessness, persistent cough and frequent chest infections